• $237.00
    Market Cap
  • -100.00%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 2
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

No data found

No data found

Peers

Statistics

More
Day Range
$0.000001
$0.000001
$0.000001
1-Year Range
$0.000001
$0.03
$0.000001
Latest Close$0.000001
Change
$0.00 (0.00%)
Volume2,000
Market Cap$237.00
Shares Outstanding237.2M
P/E (TTM)-0.00002
Diluted EPS (TTM)-$0.04
Enterprise Value$546,593.00

Information as of 05/29/2026

Company Profile

Cryomass Technologies, Inc.
https://cryomass.com
$237.00
Market Cap
-$8.8M
Net Income
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
1001 Bannock Street, Denver, CO, United States, 80204
303 416 7208

Cryomass Technologies Inc., together with its subsidiaries, develops and licenses equipment to refine harvested cannabis, hemp, and other premium crops in the United States. It offers CryoSift Separator, which capture intact cannabis and hemp trichomes. The company was formerly known as Andina Gold Corp. and changed its name to Cryomass Technologies Inc. in August 2021. Cryomass Technologies Inc. was incorporated in 2011 and is headquartered in Denver, Colorado.

Key Executives

  • Christian Noel
  • Philip Blair Mullin
  • Patricia I. Kovacevic
  • Ryan Smith
  • Stephen Schroeder

Current Ownership Distribution

  • Other224.2M (94.52%)
  • Insiders13.0M (5.48%)
  • Institutions0 (0.00%)
  • Mutual Funds0 (0.00%)